EN DE

Baiyang Investment Group (002696) Fair Value & Analysis

Consumer Defensive · CN · Market cap 1.9B CNY

BI Baiyang Investment Group 002696 · SHE
Price¥6.03
Fair Value¥2.47
Upside-59.0%
Quality49/100
Watch Baiyang Investment Group for free, get notified when fair value or trend changes. Watch for free
Expensive Growth
Thin margins · 0.4% net margin
Low debt · negative free cash flow
0.93% dividend yield
Trails peers (3/13)
Narrow moat 20/100
Evidence: High Range ¥1.85 – ¥3.08 Share as image

Fair value as of: Jul 22, 2026

From 16 valuation models · updated 19 days ago

Fair value updated Jul 22, 2026, revised from ¥3.23 to ¥2.47 (−23.5%) since Jun 25, 2026. Share price +12.1% over the past month.

Below-average quality, and screening another 59% overvalued on our models.

What matters now

  • The price sits above even our optimistic bull case (¥3.08). The favourable scenario is already priced in.
  • Solid but not exceptional quality (49/100) and above fair value, neither a clear bargain nor a standout compounder.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

¥8.17 ¥3.58 Fair Value ¥2.47 Feb 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 22, 2026.

How to read this chart

60‑month range ¥3.58 – ¥8.17 · fair‑value band ¥1.85 – ¥3.08 · the ¥6.03 price screens above the ¥2.47 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 22, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Baiyang Investment Group (002696) currently trades at ¥6.03, while our model-based Fair Value estimate is ¥2.47, implying the stock looks roughly 59.0% overvalued today. The Quality Score stands at 49/100 (below-average quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).

Over the trailing twelve months, Baiyang Investment Group generated revenue of 4.2B CNY at a net margin of 0.4%. Revenue grew 24.7% year over year. It earns a return on equity of 0.7%. Net debt stands at 520M CNY. Fundamentals as of Jul 22, 2026

Our scenario range runs from ¥1.85 (bear case) to ¥3.08 (bull case); at ¥6.03, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 23% below its 52-week high and 15% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -3% fair-value upside, at -59%, 002696 screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Residual Income ¥2.74 ¥2.65 ¥2.11 76
ROIC Compounder ¥2.95 ¥3.31 ¥3.60 72
Gordon GGM ¥0.9100 ¥1.65 ¥2.27 70
All 16 models by family
Earnings-Based
Graham-Dodd ¥0.8000 ¥3.67 ¥5.04 54
Lynch FV ¥0.9600 ¥1.38 ¥1.79 50
PEG = 1.0 ¥0.9600 ¥1.38 ¥1.79 46
EPV ¥2.95 ¥3.31 ¥3.60 59
Dividend Discount
Gordon GGM ¥0.9100 ¥1.65 ¥2.27 70
DDM Multi-Stage ¥0.9100 ¥1.50 ¥1.76 61
Multiples
P/E Multiple ¥1.85 ¥2.47 ¥3.08 63
P/S Multiple ¥1.50 ¥2.00 ¥2.50 58
P/B Multiple ¥1.50 ¥2.00 ¥2.50 55
EV/EBIT ¥4.97 ¥6.52 ¥8.06 53
EV/EBITDA ¥6.77 ¥8.91 ¥11.06 54
EV/Revenue ¥3.64 ¥5.06 ¥6.48 43
Asset-Based
NCAV (Graham) ¥1.99 ¥2.67 ¥3.98 50
Economic Profit
Residual Income ¥2.74 ¥2.65 ¥2.11 76
ROIC Compounder ¥2.95 ¥3.31 ¥3.60 72
Growth Earnings
Growth-Adj P/E ¥1.55 ¥2.21 ¥2.87 68

Widest divergence: Asset-Based (¥2.67) versus Earnings-Based (¥1.38). Highest evidence: Residual Income (76).

Notify me when 002696 reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) 4.2B CNY
Revenue growth (YoY) +24.7%
Net margin 0.4%
Return on equity 0.7%
Free cash flow −502M CNY FY2025
P/E ratio 108.0
More key figures
Operating margin 2.4%
EPS (TTM) ¥0.0500
Dividend yield 0.9%
EPS growth (YoY) -64.2%
Net debt 520M CNY FY2025

Figures from reported company fundamentals · as of Jul 22, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 49/100

Of which business quality 46 · Market factors (momentum, volatility) 38

Profitability 32
Margins and returns on capital today
Quality Growth 70
Are margins and returns improving?
Cashflow 0
Earnings quality: real cash, not paper profit
Fin. Strength 44
Balance sheet, leverage, solvency risk
Investment 79
Disciplined investing over empire-building
Low Volatility 69
Calm price path (market factor)
Momentum 21
Price trend over the last 3–12 months (market factor)
52W Momentum 30
Distance to the 52-week high (market factor)
Net Issuance 92
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Baiyang Investment Group, Inc., together with its subsidiaries, engages in the aquatic product processing and biological products, feed and feed raw materials, and deep-sea fishing businesses in China and internationally. It operates through Feed and Raw Materials, Food Processing, Ocean Fishing, and Biochemical Product segments.

Full company description

Baiyang Investment Group, Inc., together with its subsidiaries, engages in the aquatic product processing and biological products, feed and feed raw materials, and deep-sea fishing businesses in China and internationally. It operates through Feed and Raw Materials, Food Processing, Ocean Fishing, and Biochemical Product segments. The company offers tilapia, shrimp, and grass carp products under the Beifeng and Qiaoyujia brands; aquatic feed products for fish, as well as groupers, California bass, yellow catfish, large yellow croakers, and frogs; and biological products, such as collagen and gelatin for use in health products, cosmetics, beverages, food, and other fields, as well as fish collagen peptide powder and glucosamine chondroitin calcium capsules. It is also involved in aquatic research and development; aquatic fry breeding; trading; offshore fishing; lease; and research and experimental development activities. The company exports its aquatic products to the United States, Russia, Mexico, Canada, the European Union, the Middle East, and other countries and regions. The company was formerly known as Baiyang Aquatic Group, Inc. and changed its name to Baiyang Investment Group, Inc. in November 2015. Baiyang Investment Group, Inc. was founded in 2000 and is headquartered in Nanning, China.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Baiyang Investment Group reported revenue of ¥4.1B in FY2025 versus ¥2.9B in FY2021, a compound +8.7%/yr. Reported net income was ¥40.6M in FY2025, compounding +10.9%/yr from FY2021.

Growth Quality 50/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Latest Revenue (FY 2025)
4.1B CNY
Latest YoY
+31.8%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+8.1%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+10.3%
Avg. growth/yr (17Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+14.4%
Revenue +8.7%/yr
FY21 ¥2.9B
FY22 ¥3.2B
FY23 ¥2.7B
FY24 ¥3.1B
FY25 ¥4.1B
Net income +10.9%/yr
FY21 ¥26.8M
FY22 ¥62.3M
FY23 −¥27.6M
FY24 −¥15.3M
FY25 ¥40.6M

002696 screens 59% overvalued. Compare with Nestlé India Limited →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Baiyang Investment Group Fair Value". https://www.fairvalue-calculator.com/stock/002696

Peer Group

Packaged Foods · 649 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 49 · Below median
Fair Value upside −59% · Bottom 25%
Return on equity (TTM) 1% · Below median
Return on assets 1% · Below median
Net margin (TTM) 0% · Below median
Operating margin (TTM) 2% · Below median
Revenue growth 25% · Top 25%
Dividend yield (TTM) 0.9% · Below median
Debt / equity 0.21× · Higher than median

Valuation Multiples vs Packaged Foods median · lower = cheaper

P/E (TTM) 108.0× · Pricier than 75% of peers
P/B 1.36× · Cheaper than median
P/S (TTM) 0.44× · Cheaper than median
EV/EBITDA 10.8× · Pricier than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0 · sector 28
FUTURE 100 · sector 20
PAST 3 · sector 27
HEALTH 89 · sector 96
DIVIDEND 19 · sector 47

VALUE 0: the price sits above our fair-value range.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Packaged Foods stocks, each showing price versus our Fair Value estimate (as of Jul 22, 2026).

Stock Price Fair Value vs Fair Value
Nestlé India Limited NESTLEIND ₹1,427 ₹362.37 -75%
Britannia Industries Limited BRITANNIA ₹5,413 ₹1,870 -65%
Tata Consumer Products Limited TATACONSUM ₹1,089 ₹327.27 -70%
PT Indofood CBP Sukses Makmur Tbk ICBP 6,650 IDR 15,757 IDR +137%
Samyang Foods Co 003230 1,139,000 KRW 1,010,543 KRW -11%
Patanjali Foods Limited PATANJALI ₹413.80 ₹157.04 -62%
Vietnam Dairy Products Joint Stock Company VNM 58,500 VND 68,259 VND +17%
PT Mayora Indah Tbk, MYOR 1,750 IDR 2,699 IDR +54%
PT Cisarua Mountain Dairy Tbk CMRY 4,490 IDR 4,355 IDR -3%
Nongshim Co 004370 348,500 KRW 530,619 KRW +52%

Compare Baiyang Investment Group with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Baiyang Investment Group (002696) overvalued or undervalued?
As of Jul 22, 2026, our model estimates a fair value of ¥2.47 versus a price of ¥6.03, about −59% (overvalued).
What is the fair value of 002696?
Our model-based fair value for Baiyang Investment Group is ¥2.47 (as of Jul 22, 2026), built from audited fundamentals. The current price is ¥6.03.
What is the quality score of 002696?
Baiyang Investment Group has a Quality Score of 49/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Baiyang Investment Group (002696)?
Baiyang Investment Group reported trailing-twelve-month revenue of about 4.2B CNY (latest available figure, as of Jul 22, 2026).
What is the net profit margin of 002696?
The net profit margin of Baiyang Investment Group is about 0.4%, meaning it keeps roughly 0.4% of revenue as net income. Based on the latest reported figures.
Does Baiyang Investment Group pay a dividend?
Baiyang Investment Group currently shows a dividend yield of about 0.93% relative to its recent price (as of Jul 22, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Baiyang Investment Group and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.